Revolution Medicines Inc Warrant
RVMDW
23 hedge funds and large institutions have $2.2M invested in Revolution Medicines Inc Warrant in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
597% more capital invested
Capital invested by funds: $316K → $2.2M (+$1.89M)
69.03% more ownership
Funds ownership: 4.14% → 73.17% (+69%)
4% less funds holding
Funds holding: 24 → 23 (-1)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LC
Lunate Capital
Al Maryah Island, Abu Dhabi,
United Arab Emirates
|
+$66.7K |
| 2 |
DIM
DLK Investment Management
Solana Beach,
California
|
+$13K |
| 3 |
LP
LMR Partners
London,
United Kingdom
|
+$5.83K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
-$6.68K |
| 2 |
CL
CSS LLC
Chicago,
Illinois
|
-$2.31K |
| 3 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$905 |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$44 |
| 5 |
CS
Clear Street
New York
|
-$4 |
RVMDW Hedge Fund Activity: Q2 2025 in Review
23 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines Inc Warrant (RVMDW) for Q2 2025, worth a combined $2.2M — up 597% from $316K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of RVMDW and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 2 added.
The largest buyer was Lunate Capital, opening a new position worth an estimated $66.7K. The largest seller was Walleye Capital, exiting entirely with an estimated $6.68K sold.
- 23 institutional investors held Revolution Medicines Inc Warrant (RVMDW) as of Q2 2025, down from 24 in Q1 2025.
- Funds reported $2.2M of Revolution Medicines Inc Warrant stock for Q2 2025, up 597% quarter-over-quarter.
- 1 fund opened new Revolution Medicines Inc Warrant positions in Q2 2025 and 2 closed out, a net change of -1 holder.
- The largest Revolution Medicines Inc Warrant buyer in Q2 2025 was Lunate Capital, an estimated $66.7K added.
- The largest Revolution Medicines Inc Warrant seller in Q2 2025 was Walleye Capital, an estimated $6.68K sold.
Based on aggregated 13F filings for Q2 2025.